Decreased Expression of Heat Shock Protein 20 in Colorectal Cancer and Its Implication in Tumorigenesis
- Authors
- Ju, Young-Tae; Kwag, Seung-Jin; Park, Hee Jin; Jung, Eun-Jung; Jeong, Chi-Young; Jeong, Sang-Ho; Lee, Young-Joon; Choi, Sang-Kyung; Kang, Kee Ryeon; Hah, Young-Sool; Hong, Soon-Chan
- Issue Date
- Feb-2015
- Publisher
- WILEY
- Keywords
- APOPTOSIS; COLORECTAL CANCER; HEAT-SHOCK PROTEIN 20; TUMOR MARKER
- Citation
- JOURNAL OF CELLULAR BIOCHEMISTRY, v.116, no.2, pp.277 - 286
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CELLULAR BIOCHEMISTRY
- Volume
- 116
- Number
- 2
- Start Page
- 277
- End Page
- 286
- URI
- https://scholarworks.bwise.kr/gnu/handle/sw.gnu/17433
- DOI
- 10.1002/jcb.24966
- ISSN
- 0730-2312
- Abstract
- Heat shock protein 20 (HSP20), which is a member of the small heat shock protein family, is known to participate in many pathological processes, such as asthma, intimal hyperplasia, and insulin resistance. However, the function of HSP20 in cancer development is not yet fully understood. In this study, we identified HSP20 as a down-regulated protein in 20 resected colorectal cancer (CRC) specimens compared with their paired normal tissues. Because HSP20 proteins were barely detectable in HCT-116 cells (a human colorectal cancer cell line), recombinant adenovirus encoding HSP20 (Ad-HSP20) was used to induce HSP20 overexpression in HCT-116 cells. Infection of Ad-HSP20, but not control adenovirus (Ad-GFP), reduced viability, and induced massive apoptosis in a time-dependent manner. The forced expression of HSP20 enhanced caspase-3/7 activity and down-regulated the anti-apoptotic Bcl-xL and Bcl-2 mRNA and protein levels. In addition, immunohistochemical analysis of 94 CRC specimens for HSP20 protein showed that reduced HSP20 expression was related to advanced TNM stage, lymph node metastasis, and tumor recurrence. Our study shows, for the first time, that expression of the HSP20 protein has a pro-death role in colorectal cancer cells. Therefore, HSP20 may have value as a prognostic tumor marker and its overexpression might be a novel strategy for CRC therapy. (C) 2014 Wiley Periodicals, Inc.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.gnu.ac.kr/handle/sw.gnu/17433)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.